Prime Medicine Stock (NASDAQ: PRME) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 739.50K |
Day Range | - - - |
52 Wk Range | 3.47 - 12.45 |
Market Cap | $466.91M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 28.47% |
Days to Cover | 36.92 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Prime Medicine (NASDAQ:PRME) through any online brokerage.
Other companies in Prime Medicine’s space includes: KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Celcuity (NASDAQ:CELC), Inozyme Pharma (NASDAQ:INZY) and Larimar Therapeutics (NASDAQ:LRMR).
Prime Medicine has a consensus price target of $17.08.
The stock price for Prime Medicine (NASDAQ: PRME) is $3.8899 last updated September 20, 2024 at 7:57 PM EDT.
A quarterly cash dividend of 0.80 per share of Class A Common Stock. The quarterly cash dividend was payable on September 12, 2019 to stockholders of record on September 10, 2019.
Prime Medicine’s Q3 earnings are confirmed for Friday, November 1, 2024.
There is no upcoming split for Prime Medicine.
Prime Medicine is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.